Obesity and Pregnancy
/Definition and Epidemiology
Obesity - classified by BMI
Prevalence of obesity has increased to 34.0% in women 20-39 years in 2010
Effect of Obesity on Pregnancy
Pregnancy Loss
Increased risk of SAB (1.2 OR) and recurrent miscarriage (OR 3.5)
Also have increased risk of pregnancies affected by neural tube defects, hydrocephaly, and other anomalies
Pregnancy Complications
Antepartum
Medical issues: increased risk of cardiac dysfunction, proteinuria, sleep apnea, nonalcoholic fatty liver disease
Pregnancy issues: increased risk of gestational diabetes, preeclampsia, stillbirth
Risk of stillbirth increases with increasing obesity
OR 1.71 for BMI 30-34.9
OR 2.0 for BMI 35.0-39.9
OR 2.48 for BMI >40
OR 3.16 for BMI > 50
Of note, the practice bulletin does point out that black pregnant people with obesity have a higher risk of stillbirth than white pregnant people - discusses that while this is not a biological reason, is a proxy for likely negative influence of racism on health
Intrapartum
Increased risk of cesarean delivery, failed trial of labor, endometritis, wound rupture/dehiscence, and venous thrombosis
Decreased likelihood of VBAC after TOLAC
Postpartum Complications - increased risk of future metabolic dysfunction
Fetal complications - increased risk of growth abnormalities
How Can We Manage Obesity Before And During Pregnancy
Pre-pregnancy Counseling
Discussion of control of obesity with weight loss (either surgical or non-surgical)
Even small weight loss can be associated with improved outcomes (even 5-10%)
Can try motivational interviewing
Encourage diet, exercise, and behavior modification
Medications
Not recommended pre-pregnancy or during pregnancy
During Pregnancy
Recommended weight gain
Overweight: recommend 15-25 lb weight gain
Obese: recommend 11-20 lb weight gain
There is a lack of data regarding short-term and long-term maternal and newborn outcomes, no recommendation for lower targets for pregnant women with more severe degrees of obesity
Congenital Anomalies
As previously discussed, increased risk of congenital anomalies, but detection of these anomalies is significantly decreased with increasing maternal BMI
Cell-free DNA test failures are also more frequent in patients that are obese. This is because a minimum fetal fraction of 2-4% usually is needed. The median fetal fraction between 10-14 weeks is around 10%, but with increasing BMI, it’s associated with decreased fetal fraction.
Can consider repeating screening if it’s because of early gestation, but not recommended if there are ultrasound findings of anomalies
Metabolic Disorders - screen for glucose intolerance and OSA at first antenatal visit with history, exam, and labs
Sleep medicine evaluation
Can consider early glucose screening; if negative, repeat at usual time of 24-28 weeks
Stillbirth and Antepartum fetal testing
This is going to be different based on your institution
Can consider weekly testing after 37 weeks for BMI 35-39.9
Can consider weekly testing after 34 weeks for BMI >40
Intrapartum
Many studies that show an increased risk of C-section among overweight and obese women
There are studies that show an increased length of time in labor; another study showed that maternal BMI was not associated with longer second stage
Maybe consider allowing more time in first stage of labor before C-section in obese individuals?
Remember that pregnant women with higher BMI have a higher rate of complications with elective repeat cesarean section - so not a reason to not TOLAC them!
Some considerations during labor
Consider anesthesia consult - especially if OSA. An epidural may be technically more difficult to place
Antibiotics - may need to increase the amount of Ancef before C-section (remember usual is 2g). Increase to 3g if >120 kg
Postpartum
There is an increased risk of VTE in obese women, so definitely use your SCDs and encourage early mobilization
In very high risk groups, discuss pharmacologic thromboprophylaxis
Dose can be BMI stratified
BMI < 40: 40 mg Lovenox daily
If BMI 40-59.9: 40 mg BID
If BMI 60 or greater: 60 mg BID